Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-03Clinical Trial Update: Cell-free DNA Methylation for Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial update investigating cell-free DNA methylation as a biomarker in epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Anti-PD-L1 and SAbR for Ovarian Cancer [Phase 2]
Phase 2 trial of anti-PD-L1 therapy with SAbR (stereotactic ablative radiotherapy) in recurrent epithelial ovarian/fallopian tube/primary pe…
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation [Phase 3]
Phase 3 randomized trial investigating HIPEC in recurrent ovarian cancer patients with HRR gene mutations; status not yet determined.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS) [Phase 3]
Phase 3 trial investigating stratified evaluation of PDS and NACT-IDS in ovarian cancer is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: 68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings [Phase 2]
Phase 2 trial evaluating 68Ga-FAPI-04 and 18F-FDG PET/CT in epithelial ovarian cancer with comparison to histology findings.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers [EARLY_Phase 1]
Early-phase study evaluating pembrolizumab in gynecologic cancers; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer [Phase 3]
Phase 3 trial comparing mirvetuximab soravtansine to investigator's choice chemotherapy in FR alpha-positive advanced epithelial ovarian, pr…
-
CLINICAL_TRIALS trial_result · 2020-05-29Clinical Trial Update: Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update on cytoreductive surgery with HIPEC using lobaplatin for advanced and recurrent epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial comparing karenitecin to topotecan in advanced epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial update for tivozanib in recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer [Phase 2, Phase 3]
Clinical trial update for intraoperative hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer completed across Phase 2 and…
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial assessing bevacizumab and trabectedin with or without carboplatin in recurrent ovarian epithelial cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of HIPEC following cytoreductive surgery for advanced epithelial ovarian cancer (including …
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update evaluating Granulocyte Colony Stimulating Factor for prevention of febrile neutropenia in epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating VTX-2337 with pegylated liposomal doxorubicin in recurrent or persistent epithelial ovarian, fallopian tube, or pri…
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Phase III Trial of Stage I Ovarian Cancer After Surgery [Phase 3]
Phase III trial update for stage I ovarian cancer after surgery is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for ganetespib (GANNET53) in metastatic p53-mutant platinum-resistant ovarian cancer; trial terminated with posted res…
-
FDA approval · 2019-06-27FDA Approved: ZIRABEV — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves ZIRABEV (bevacizumab-bvzr) from Pfizer as a biosimilar to Avastin under an Original Application. The approval covers multiple b…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating MESO-CAR T cell therapy for relapsed and refractory epithelial ovarian cancer. Status not disclosed in…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer [EARLY_Phase 1]
An early-phase study evaluating anti-mesothelin CAR NK cells for epithelial ovarian cancer is underway; sponsorship is Allife Medical Scienc…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Long-acting G-CSF for Febrile Neutropenia [Phase 3]
Phase 3 trial update on a long-acting G-CSF for febrile neutropenia in patients with epithelial ovarian cancer; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer [Phase 3]
Phase 3 trial evaluating hyperthermic intraperitoneal chemotherapy with paclitaxel in advanced epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 study evaluating NY-ESO-1 overlapping peptides in epithelial ovarian, fallopian tube, or primary peritoneal cancer completed with re…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy
A terminated clinical trial update investigating the serum biomarker YKL-40 in patients with newly diagnosed stage III-IV ovarian epithelial…
-
CLINICAL_TRIALS trial_result · 2018-01-24Clinical Trial Update: Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating HIPEC as neoadjuvant chemotherapy and postoperative chemotherapy for advanced epithelial ovarian cancer …